Yiqi Yang
Biographic Data
| ID | 7279990 |
|---|---|
| NAME | Yiqi Yang |
| GIVEN NAMES | Yiqi |
| FAMILY NAME | Yang |
| SIGNATURE | YANG Y |
| AFFILIATIONS | Guangdong Pharmaceutical University |
| ORCID | 0000-0002-0116-3827 |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2/glycolysis pathway
The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs
Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis
No prominent works on this page.
Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs
The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease
Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2/glycolysis pathway
Internal Medicine (4 works) · Medicine (4 works) · Biochemistry (3 works) · Endocrinology (3 works) · Pharmacology (3 works) · Biology (2 works) · Chemistry (2 works) · Chronic Kidney Disease and Diabetes (2 works) · Diabetes mellitus (2 works) · Kidney (2 works)